Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogenic pooled olfactory mucosa-derived mesenchymal stem cells
- Development stage
- Phase 2
- Lead developer
- Institute of Biophysics and Cell Engineering
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Allogenic pooled olfactory mucosa-derived mesenchymal stem cells (OM-MSCs) is a cell therapy product developed by the Institute of Biophysics and Cell Engineering of the National Academy of Sciences of Belarus. This therapeutic consists of mesenchymal stem cells harvested from the olfactory mucosa of healthy donors, which are then expanded and pooled. Administered intravenously, these cells are designed to treat severe COVID-19 associated interstitial pneumonia by leveraging the natural immunomodulatory and anti-inflammatory properties of MSCs. The primary goal is to mitigate the systemic inflammatory response (cytokine storm) and promote the regeneration of damaged lung tissue in patients with respiratory distress.
- Other names
- olfactory mucosa-derived mesenchymal stem cellsOM-MSCsallogenic pooled OM-MSCs
Beyond the preview
Go deeper on allogenic pooled olfactory mucosa-derived mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogenic pooled olfactory mucosa-derived mesenchymal stem cells.